[S-17] To pursue the best treatment of MG

[S-17-3] Complement Inhibition in the Treatment of Myasthenia Gravis

^○James F. Howard Jr (The University of North Carolina at Chapel Hill, USA)

Dr. Howard received his MD degree from the University of Vermont School of Medicine. He completed his residency in Neurology and fellowship training in Neuromuscular Disorders-EMG at the University of Virginia. He joined the Department of Neurology at The University of North Carolina at Chapel Hill in 1979 and became Chief of the Neuromuscular Disorders Section in 1996. He is the Director of the MDA Clinic and Medical Director of the EMG Section of the Clinical Neurophysiology Laboratory.

He is a fellow in the American Academy of Neurology and the American Association of Neuromuscular and Electrodiagnostic Medicine. He is member of the American Neurological Association. Dr. Howard serves as a member of the National Medical/Scientific Advisory Board of the Myasthenia Gravis Foundation of America and was a prior member of the Medical Advisory Committee of the Muscular Dystrophy Association. Dr. Howard has served previously as a member of the Board of Directors for the American Association of Neuromuscular & Electrodiagnostic Medicine, the American Board of Electrodiagnostic Medicine and as a member of the Executive Committee for the Muscle Study Group and as Chair of the National Medical/Scientific Advisory Board of the Myasthenia Gravis Foundation of America.